Abstract

Postherpetic Neuralgia

Author(s): Angelle Patsy

Issue: Jan/Feb 2000 - Compounding for Pain Management

Page(s): 27-29

Download in electronic PDF format for $75

Abstract

Postherpetic neuralgia is the result of damage to the nervous system by an acute herpes zoster infection. The author presents three case reports illustrating the benefits of a multifaceted treatment approach. She concludes that postherpetic neuralgia results in a continuous and prolonged excitation at the pain receptor sites. The success of adjunctive topical treatment using multiple agents that possess varied modes of action substantiates the possibility of improving therapeutic modalities in this patient population. The collaborative efforts of the health-care team are extremely important.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2000 Pg. 27-29	Postherpetic Neuralgia Author(s): Angelle Patsy
Jul/Aug 1999 Pg. 309-310	Acidifying Agents, Featured Excipient: Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 410	Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion Author(s): Allen Loyd V Jr
Mar/Apr 2007 Pg. 131	Case Report: Shingles Triple Cream in the Treatment of Herpes Zoster Author(s): Fields Shannon W
May/Jun 2016 Pg. 231	Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 135	Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Author(s): Allen Loyd V Jr
Mar/Apr 2000 Pg. 133	Ketamine HCl 10%, Gabapentin 6%, Baclofen 2%, Amitriptyline HCl 2% and Clonidine HCl 0.1% in PLO Author(s): Allen Loyd V Jr
May/Jun 1998 Pg. 206-207	Veterinary 2-deoxy-D-glucose Ophthalmic Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2004 Pg. 46-48	Basics of Compounding for Disorders of the External Ear Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 126-129	Basics of Compounding for the Treatment of Warts Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 265	Miconazole Nitrate 2%, Deoxy-D-Glucose 0.2%, and Hydrocortisone 0.4% Lip Balm Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 206-209	Basics of Compounding for Cold Sores or Fever Blisters Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 132-134	Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection Author(s): Zhang Yan-ping, Trissel Lawrence A
Jan/Feb 2000 Pg. 72-75	Physicochemical Stability of Compounded Creams Containing alpha-Hydroxy Acids Author(s): de Villiers Melgardt M, Narsai Kirti, van der Watt Jakkie G
Sep/Oct 2015 Pg. 367-373	Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries Author(s): Guth Michael AS
May/Jun 2025 Pg. 208	Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion Author(s):
Nov/Dec 2006 Pg. 456	Gabapentin 100-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2002 Pg. 42	Clonidine HCl 0.2%, Gabapentin 6%, and Ketamine HCl 10% in a Pluronic Lecithin Organogel (PLO) Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 185	Clonidine HCl 0.2%/Gabapentin 6%/Ketamine HCl 10% in Pluronic Lecithin Organogel (PLO) Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 1998 Pg. 190	Sodium Acetate-Boric Acid-Acid Stock Solution for Ophthalmic Preparations Author(s): Allen Loyd V Jr